Celerion Launches Electronic Laboratory Notebook
Celerion
announces implementation of the electronic laboratory notebook in its global bioanalytical network. Celerion designed and implemented
Labnotes
, a commercially available electronic laboratory notebook system to standardize bioanalytical processes and improve documentation consistency for all studies.
Clients benefit from faster access to data and improved information quality due to centralized data repositories. Real time data integrity eliminates manual calculations and sources of potential error.
The electronic laboratory notebook has built-in calculations for critical aspects of the bioanalytical workflow, standardizing everything from reference standards, to instrument and pipette calibration. The system increases consistency and significantly reduces sources of manual error. The electronic laboratory notebook is validated to OECD GLP and FDA 21 CFR Part 11 computerized system regulatory requirements.
Celerion collaborated with Laboratory Data Solutions Ltd on their Labnotes electronic laboratory notebook product. “We are delighted to have worked with Celerion on implementing the Labnotes solution” said Jeremy Cook, Director of Laboratory Data Solutions. “The team at Celerion has invested significant time in ensuring the system is completely integrated into the bioanalytical workflow..”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
